Safety and efficacy of atezolizumab (atezo) in patients (pts) with autoimmune disease (AID): Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinoma

Y. Loriot, C. N. Sternberg, D. Castellano Gauna, H. Dumez, R. Huddart, K. M. Vianna, T. Alonso Gordoa, I. A. Skoneczna, A. Fay, C. S. P. Sacco, F. Nole, F. Massari, B. Brasiuniene, P. Maroto, S. F. Oosting, S. Fear, F. Di Nucci, S. De Ducla, E. Choy

    Research output: Contribution to journalMeeting AbstractAcademic

    Original languageEnglish
    Pages (from-to)368-369
    Number of pages2
    JournalAnnals of Oncology
    Volume30
    Publication statusPublished - Oct-2019
    Event44th Congress of the European-Society-for-Medical-Oncology (ESMO) - Barcelona, Spain
    Duration: 27-Sept-20191-Oct-2019

    Cite this